Jean-Pascal Machiels

7.4k total citations · 3 hit papers
36 papers, 4.5k citations indexed

About

Jean-Pascal Machiels is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jean-Pascal Machiels has authored 36 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Jean-Pascal Machiels's work include Head and Neck Cancer Studies (6 papers), Renal cell carcinoma treatment (4 papers) and HER2/EGFR in Cancer Research (4 papers). Jean-Pascal Machiels is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Renal cell carcinoma treatment (4 papers) and HER2/EGFR in Cancer Research (4 papers). Jean-Pascal Machiels collaborates with scholars based in Belgium, France and United States. Jean-Pascal Machiels's co-authors include Johann S. de Bono, Stéphane Oudard, Gwénaëlle Gravis, I. Bodrogi, Sunil Gupta, Liji Shen, Oliver Sartor, Ivo Kocák, Martin Roessner and Mustafa Özgüroğlu and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jean-Pascal Machiels

34 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

2010 2.4k citations Johann S. de Bono, Stéphane Oudard et al. The Lancet profile →
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

2012 336 citations Kenneth J. Pienta, Jean-Pascal Machiels et al. Investigational New Drugs profile →
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

2019 299 citations Jean-Pascal Machiels et al. profile →

Peers

Countries citing papers authored by Jean-Pascal Machiels

Since Specialization

Citations

This map shows the geographic impact of Jean-Pascal Machiels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Pascal Machiels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Pascal Machiels more than expected).

Fields of papers citing papers by Jean-Pascal Machiels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Pascal Machiels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Pascal Machiels. The network helps show where Jean-Pascal Machiels may publish in the future.

Co-authorship network of co-authors of Jean-Pascal Machiels

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Pascal Machiels. A scholar is included among the top collaborators of Jean-Pascal Machiels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Pascal Machiels. Jean-Pascal Machiels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up 2022 ·ESMO Open ·C. van Herpen, Vincent Vander Poorten, Alena Skálová, Chris H.J. Terhaard, Roberto Maroldi, (unknown), B. Baujat, Laura D. Locati, Alexandra Jensen, Ludi E. Smeele, José A. Hardillo, (unknown), Annalisa Trama, (unknown), (unknown), Jean-Pascal Machiels	84
2	Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck 2020 ·Molecular Cancer Therapeutics ·(unknown), Sandra Schmitz, (unknown), (unknown), Sébastien Pyr dit Ruys, Pierre P. Roger, Didier Vertommen, Jean-Pascal Machiels	16
3	Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 ‘Best of’ and 24954 ‘larynx preservation’ study 2018 ·European Journal of Cancer ·Christian Simon, Carmela Caballero, Vincent Grégoire, Dietmar Thurnher, Petri Koivunen, Philippe Céruse, Giuseppe Spriano, Piero Nicolai, Lisa Licitra, Jean-Pascal Machiels, Marc Hamoir, Guy Andry, Hisham Mehanna, Keith D. Hunter, Andreas Dietz, C. René Leemans	10
4	Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer 2016 ·The Oncologist ·Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, Nancy Lewis, Michaela J. Higgins, Kari B. Wisinski, Ahmad Awada, Michela Maur, Mark N. Stein, (unknown), Rebecca Mosher, Ernesto Wasserman, (unknown), Hefei Zhang, (unknown), Mohamed Elmeliegy	48
5	Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials 2016 ·Clinical Genitourinary Cancer ·Petri Bono, Stéphane Oudard, I. Bodrogi, Thomas E. Hutson, Bernard Escudier, Jean-Pascal Machiels, John A. Thompson, Robert A. Figlin, Alain Ravaud, Mert Başaran, Camillo Porta, Sergio Bracarda, Thomas Brechenmacher, (unknown), Maurizio Voi, Viktor Grünwald, Robert J. Motzer	8
6	An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors 2014 ·Cancer Chemotherapy and Pharmacology ·Pierre Maison‐Blanche, Shaker R. Dakhil, Ari David Baron, Sylvie Rottey, (unknown), Gedske Daugaard, Jean-Pascal Machiels, William R. Conkright, Sunil Sharma, Patricia M.M.B. Soetekouw, Jeffrey Yachnin, Lisa Sengeløv, Peter J. Van Veldhuizen, Sanjiv S. Agarwala, Dorothée Sémiond, Mustapha Chadjaa, Liji Shen, James L. Wade	1
7	Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions 2013 ·Cancer Treatment Reviews ·Sandra Schmitz, Kie Kian Ang, Jan B. Vermorken, Robert I. Haddad, Carlos Suárez, Gregory T. Wolf, Marc Hamoir, Jean-Pascal Machiels	62
8	Tamoxifen and Ovarian Function 2013 ·PLoS ONE ·Martine Berlière, François P. Duhoux, Florence Dalenc, (unknown), (unknown), Christine Galant, Aline van Maanen, (unknown), Jean-Pascal Machiels	25
9	Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone 2012 ·Clinical Cancer Research ·Charles J. Ryan, Mark Rosenthal, Siobhan Ng, Joshi J. Alumkal, Joel Picus, Gwénaëlle Gravis, Karim Fizazi, Frédéric Forget, Jean-Pascal Machiels, Sandy Srinivas, Min Zhu, Rui Tang, Kelly S. Oliner, Yizhou Jiang, Elwyn Loh, Sarita Dubey, Winald R. Gerritsen	64
10	Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: Case report and review of the literature 2012 ·Head & Neck ·Isabelle Sinapi, Benoı̂t Navez, Marc Hamoir, Sandra Schmitz, Jean-Pascal Machiels, (unknown), Marc Van den Eynde	16
11	Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer breakdown → 2012 ·Investigational New Drugs ·Kenneth J. Pienta, Jean-Pascal Machiels, Dirk Schrijvers, B. Yа. Alekseev, М. I. Shkolnik, Simon J. Crabb, Susan Li, Shobha Seetharam, Thomas A. Puchalski, Chris H. Takimoto, Yusri Elsayed, Fitzroy W. Dawkins, Johann S. de Bono	336
12	An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer 2012 ·The Breast ·Fátima Cardoso, Jean‐Luc Canon, Dino Amadori, D. Aldrighetti, Jean-Pascal Machiels, (unknown), Lev Verkh, Tiziana Usari, Kenneth A. Kern, C. Giorgetti, Luc Dirix	12
13	Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis 2012 ·Oral Oncology ·Remco de Bree, Missak Haigentz, Carl E. Silver, Daniela Paccagnella, Marc Hamoir, Dana M. Hartl, Jean-Pascal Machiels, Vinidh Paleri, Alessandra Rinaldo, Ashok R. Shaha, Robert P. Takes, C. René Leemans, Alfio Ferlito	27
14	Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment 2012 ·Oral Oncology ·Missak Haigentz, Dana M. Hartl, Carl E. Silver, Johannes A. Langendijk, Primož Strojan, Vinidh Paleri, Remco de Bree, Jean-Pascal Machiels, Marc Hamoir, Alessandra Rinaldo, Daniela Paccagnella, Ashok R. Shaha, Robert P. Takes, Alfio Ferlito	45
15	Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial 2011 ·The Lancet Oncology ·Jean-Pascal Machiels, (unknown), Ágnes Ruzsa, Gábor Répássy, Igor Lifirenko, (unknown), Per Soelberg Sørensen, Tina Nielsen, Steen Lisby, Paul M. Clément	163
16	A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings 2010 ·Cancer Immunology Immunotherapy ·Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugéniu Banu, Jean-Pascal Machiels, Marion Baudard, François Ringeisen, Thierry Velu, Marie‐Aude Lefrère‐Belda, Jean‐Marc Limacher, Wolf H. Fridman, Michel Azizi, Bruce Acres, Éric Tartour	71
17	Amplification of epidermal growth factor receptor gene in renal cell carcinoma 2010 ·European Journal of Cancer ·Iman El‐Hariry, Thomas Powles, Mike Lau, Cora N. Sternberg, Alain Ravaud, Hans von der Maase, Niko Zantl, Peter Harper, Frédéric Rolland, B. Audhuy, (unknown), Jean-Pascal Machiels, (unknown), (unknown), Robert E. Hawkins	8
18	Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial breakdown → 2010 ·The Lancet ·Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu, Steinbjørn Hansen, Jean-Pascal Machiels, Ivo Kocák, Gwénaëlle Gravis, I. Bodrogi, Mary J. MacKenzie, Liji Shen, Martin Roessner, Sunil Gupta, Oliver Sartor	2397
19	The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. 2001 ·PubMed ·R. Todd Reilly, Jean-Pascal Machiels, Leisha A. Emens, Anne M. Ercolini, Francesca I. Okoye, R.Y. Lei, (unknown), Elizabeth M. Jaffee	122
20	Reversible myocardial dysfunction in a patient with alcoholic ketoacidosis: A role for hypophosphatemia 1998 ·The American Journal of Emergency Medicine ·Jean-Pascal Machiels, (unknown), Julian Donckier, Etienne Installé	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact